2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Facial Blendshape Index(FBI) for Quantification of Hypomimia on Parkinson´s Disease

B. Koyak, T. Menzel, M. Botsch, A. Spottke, M. Reuter, U. Wüllner, NA. Aziz (Dortmund, Germany)
Facial Synkinesis: Can It Have a Central Origin?

J. Patino (Houston, USA)
Facilitators and Barriers to Exercise Program Implementation in Parkinson’s Disease Rehabilitation: A Comprehensive Review Using the Consolidated Framework for Implementation Research

M. M. Elsayed, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah (Mansoura, Egypt)
Factors contributing to balance discordance and its impact on fear of falling avoidance behavior in Parkinson’s disease

S. Conklin, D. Peterson, A. Hooyman, J. Longhurst (Saint Louis, USA)
Fahr’s Disease: A Response To Patient Perspectives of Presentation and Clinical Expectations

A. Tate, A. Batla (Melton Mowbray, United Kingdom)
Falls in Parkinson Disease, Videonystagmography and Fear of Falls – an Exploratory Study.

I. Monteiro, M. Salmito, K. Aguiar, F. Rolim, M. Rela, A. Ferreira Gomes, F. Carvalho (Fortaleza, Brazil)
Familial parkinson disease A comparative study between LRRK2 and PINK 1 mutations

A. Mousli, R. Zouari, Z. Saeid, F. Nabli, A. Rachdi, D. Ben Mohamed, S. Ben Sassi (Tunis, Tunisia)
Family History of Parkinson’s Disease in Patients with Essential Tremor and in Patients with Parkinson’s Disease and Its Association with Different Phenotypes.

R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)
Fatigue in Parkinson’s Disease: A Case-Control Cross-Sectional Study in a Rural Indian teaching hospital

D. Desai, S. Desai (Anand, India)
Fatigue In Parkinson’s Disease: Is It Primary or Secondary?

A. Mansour, M. Hegazy, E. Awad, A. Gaber (Cairo, Egypt)
Fatty Acid Metabolic Reprogramming Regulates Glial-Epithelial Axis via Nur77 Palmitoylation in Intestinal Dysfunction in Parkinson’s Disease

J. Zou, Z. Deng, Z. Lu, X. Luo, F. Yu, W. Bi (Guangzhou, China)
Feasibility of AI-Assisted Screening for Early Parkinson’s in Resource-Limited Settings

F. Zaier, M. Zribi (Tunis, Tunisia)
Feasibility of Telemedicine Approaches in the OxQUIP Study

N. Conway, J. Huxley, C. Sotirakis, M. Gibbs, A. D'Souza, B. Cooley, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Feature Extraction and Classification Using Smartphone-Based Alternating Tapping Tasks for Distinguishing Parkinson’s Disease from Healthy Individuals

V. Ratanasirisawad, P. Panyakaew, O. Phokaewvarangkul, J. Sringean, R. Bhidayasiri (Bangkok, Thailand)
Fecal Microbiota Transplantation for Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Menegaz Ms, J. Martinez-Lemus Md, í. Barros Andrade, F. Tamashiro Ms, F. Westphal Filho, P. Moss Ms, J. Patiño Md, M. Schiess Md (Houston, USA)
Ferritin-related Brain Iron Deposition in Parkinson’s Disease Involves α-Synuclein Pathology

L. Luo, D. Su, Z. Yu, T. Feng (Beijing, China)
Finding Prodromal Parkinson’s Disease with the Movement Disorder Society’s Prodromal Calculator and Electronic Health Records

J. Heller, K. Fitzgerald (Baltimore, USA)
Findings of motoric and neuro psychological outcome using high frequency stimulations in Parkinsons with STN-DBS

A. Dabbeta, V. Rama Raju (Hyderabad, India)
First in Class ASO Targeting A53T Allele: Preclinical Efficacy

S. Smieszek, B. Przychodzen, C. Tyner, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)
First Insights into Genetic Findings from the Mexican Parkinson’s Research Network (MEX-PD): The Case of MTHFR

P. Reyes-Pérez, A. Lazaro-Figueroa, I. Estrada-Bellmann, Y. Matuk-Pérez, C. Guerra-Galicia, K. Salinas-Barboza, E. Morelos Figaredo, N. Gandarilla-Martínez, V. Flores-Ocampo, E. Waldo, A. Zayas-Del Moral, I. Espinosa-Méndez, M. Inca-Martinez, U. Caballero-Sánchez, T. P. Leal, I. Mata, E. Gaspar-Martínez, M. Rentería, S. Alcauter-Solorzano, A. Ruiz-Contreras, A. Medina-Rivera (Queretaro, Mexico)
First preliminary Experience of Tele-medicine in Deep Brain Stimulation in Middle East

M. Badr (Tanta, Egypt)
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ARV-102, a PROTAC LRRK2 Degrader, in Healthy Participants

L. Smits, Y. Zhang, C. Woodward, S. Aksenov, A. Costa Zaninotto, C. Donnelly, T. Storz, Y. Folami, P. Patel, C. Lubeski, M. Macdougall, K. Kelly, A. Hendricson, S. Korsten, P. Kremer, A. Cacace, I. Conti (Leiden, Netherlands)
Focal Dystonic Hand Tremor Secondary to Distal Traumatic Peripheral Nerve Injury

E. Hogg, C. Lam, M. Tagliati (Los Angeles, USA)
Focal Lower Limb Myoclonus Heralding Adult Onset Fulminant SSPE

S. Jha, S. Pendyala (Kolkata, India)
Food-Related Predictors of Parkinson Progression

L. Mischley, J. Farahnik, M. Murawska (Kenmore, USA)
Force Estimation as a Method to Assess Proprioception in Parkinson’s Disease Patients

M. Wilken, G. Bianchi, M. Martínez Sucre, C. Cruz Molina, G. Noel, D. Andres, M. Merello (Buenos Aires, Argentina)
Foscarbidopa/Foslevodopa Therapy Improves Continuous Duration of Good ON Time and Correlated With Quality of Life in People With Parkinson’s Disease

M. Bouchard, R. Hauser, P. Odin, D. Kern, S. Isaacson, L. Bergmann, L. Harmer, J. Homola, R. Gupta, C. Yan, C. Carroll (North Chicago, USA)
Freezing of Gait Detection and Warning System for Parkinson’s Patients

D. Kusbeci, T. Ozkarslioglu, N. Durmaz Celik, Z. Saatci (Izmir, Turkey)
Frequency and outcome of PEG tube implantations in hospitalized Parkinson’s disease patients

R. Burke, T. Mehta, H. Kamo, M. Okun, C. Hess, M. Remz (Gainesville, USA)
Frequency and Phenotype of GAA-FGF14 Disease in Bilateral Vestibulopathy Syndromes: Insights from Repeat Expansion Carriers, Including a Dual Diagnosis with RFC1-Related CANVAS

D. Pellerin, F. Heindl, A. Traschütz, MJ. Dicaire, AM. Hartmann, D. Rujescu, H. Houlden, B. Brais, M. Strupp, M. Synofzik (London, United Kingdom)
Frequency of Falls in the Parkinson’s Progression Markers Initiative

J. Vizcarra, D. Lafontant, A. Siderowf (Philadelphia, USA)
Frequency of Overweight and Obesity in a Cohort of Parkinson’s Disease Patients

K. Aguiar, I. Monteiro, A. Ferreira Gomes, I. Santos, F. Rolim, A. Lima Verde, A. Carioca, F. Carvalho (Fortaleza, Brazil)
Frequency of Shingles Infection In Parkinson Patients: Data From Bilkent City Hospital Cohort

T. Pak, G. çetin Onar, A. Hareket, O. Gençler, N. ünal, E. Dirik, Y. Sücüllü Karadağ (İNCEK, Turkey)
Friedreich Ataxia Versus Ataxia With Vitamin E Deficiency : A Comparative Study Of Electrophysiological Features

R. Zouari, L. Hlioui, R. Amouri, C. Jeridi, D. Ben Mohamed, MZ. Saeid, A. Rachdi, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
From Campotomy to MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson’s: A Systematic Review in the Context of a Phase III Study

C. Ferrer, A. Sanchez Fraga, L. Knight, R. Martuscello, K. Gant, A. Leruste, A. Grinspan (Munich, Germany)
From Explainable AI to Biomarkers: Identifying Disease-Related Brain Regions in Spinocerebellar Ataxia Type 3

P. Wegner, M. Ferreira, J. Theisen, T. Klockgether, J. Faber (Bonn, Germany)
From Subclinical Symptoms to Post-Surgical Challenges: A Pediatric Case of Craniopharyngioma

M. Gomez Rodriguez, H. Torocsik (Pembroke Pines, USA)
From syndrome to genetics: Genetic Etiologies of Dystonia with Anarthria/Aphonia

A. Menetrey, E. Rayco, M. Emamikhah Abarghouei, A. Lang, C. Gorodetsky, C. Ganos (Toronto, Canada)
Frontal and Motor TMS Evoked Potentials Predict Response to Ventriculoperitoneal Shunt in NPH

T. Davidi, S. Anis, Y. Zauberman, T. Fay-Karmon, A. Saar, N. Zifman, H. Fogel, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)
Full-year Open-label Tracking of Adaptive Deep Brain Stimulation in Parkinson’s Disease in Two Patients: Considerations for Long-term Algorithm Maintenance

J. Yao, M. Shcherbakova, A. Hahn, L. Hammer, S. Cernera, C. Oehrn, S. Little, P. Starr (San Francisco, USA)
Functional Activity of Apomorphine Relative to Dopamine at Dopamine Receptors: Findings from G Protein Coupled Receptor Biosensor Assays

B. Yegla, P. Jenner, M. Grall, J. Rubin (Rockville, USA)
Functional Alterations in Early-Stage Parkinson’s Disease and Multiple System Atrophy with REM Sleep Behavior Disorder

SC. Wang, Y. Xiao, YB. Hou, CY. Li, RW. Ou, JY. Lin, TM. Yang, NN. Che, QR. Jiang, XT. Zheng, JY. Liu, HF. Shang (Chengdu, Sichuan, China)
Functional and Biomechanical characterization through the progression of Parkinson’s Disease

L. Albarnez, M. San Martín, R. Montefusco (Valdivia, Chile)
Functional and Neuroplastic Changes Following a 4-Week Non-Motorized Treadmill Training Program: A Pilot Study

A. Boddy, C. Smith, O. Salmon, M. Mastrodicasa, A. Silva, T. Barrett (Waco, USA)
Functional Segregation in Parkinson’s Disease

DN. Su, J. Hanania, A. Pavel, M. Matarazzo, J. Mckenzie, J. Cheng, N. Vafai, S. Dhaliwal, V. Sossi, A. Stoessl (Beijing, China)

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z